摘要
The effect of IL-17A in diabetic kidney disease (DKD) has received increasing attention. Interleukin (IL)-17A promotes renal inflammation and the progression of DKD, and IL-17A deficiency improves experimental DKD. However, recent studies have found that the effect of IL-17A on DKD is more complicated than the negative impact. IL-17A alleviates renal inflammation and fibrosis via regulating autophagy or the macrophage phenotype. Moreover, paradoxical expression of IL-17A has been reported in human DKD. This review focuses on how IL-17A affects the progression of DKD and the resulting opportunities and challenges.
学科与关键词
关键词
Diabetic kidney diseaseIL-17AInflammationFibrosis
- Rab27a promotes diabetic kidney disease progression by affecting m6A levels in renal tubular epithelial cellsWenhui, D.; Yaoming, X.59th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), Hamburg, GERMANY, 2023-10-02 To 2023-10-06.
- The Effect of Allograft Inflammatory Factor-1 on Inflammation, Oxidative Stress, and Autophagy via miR-34a/ATG4B Pathway in Diabetic Kidney DiseaseJianbing, Hao*; Xiaotian, Liu; Jie, Tang; Xueying, Chang; Honge, Jin; Bo, Zhu; Lirong, Hao*; Lei, ZhangOxidative Medicine and Cellular Longevity, 2022, 2022: 1668000.被引 8
- Dapagliflozin reverses the imbalance of T helper 17 and T regulatory cells by inhibiting SGK1 in a mouse model of diabetic kidney diseaseWang, Dan; Zhang, Zikun; Si, Zekun; Yang, Yanlin; Li, Shuangshuang; Xue, Yaoming*FEBS Open Bio, 2021, 11(5): 1395-1405.被引 14
